Use of First- and Second-Generation Cyclooxygenase-2–Selective Nonsteroidal Antiinflammatory Drugs and Risk of Acute Myocardial Infarction
Frank Andersohn(Charité - Universitätsmedizin Berlin), Edeltraut Garbe(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Samy Suissa(Jewish General Hospital)
Cited by 176
Related Papers
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
|New England Journal of Medicine|2007|714
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
|Annals of Internal Medicine|2007|476